Junfei Cheng
Impact in
-
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
Papers in ⓘ
-
- Protein Degradation and Inhibitors 9
- Ubiquitin and proteasome pathways 8
- Biochemical and Molecular Research 2
- Histone Deacetylase Inhibitors Research 1
- Cancer therapeutics and mechanisms 1
- Oncology 5
- Peptidase Inhibition and Analysis 3
- Co-authors
- Chunquan Sheng (12 shared papers)Guoqiang Dong (11 shared papers)Shipeng He (6 shared papers)Ying Wu (2 shared papers)Shanchao Wu (2 shared papers)Yu Li (1 shared paper)Xu Wang (1 shared paper)Min Huang (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)ACS Medicinal Chemistry Letters (1 paper)Bioorganic & Medicinal Chemistry (1 paper)ChemBioChem (1 paper)Chinese Chemical Letters (1 paper)
- Partner nations
- China
In The Last Decade
Junfei Cheng
12 papers receiving 360 citations
Peers
Comparison fields: 5 of 46
- Hematology 61
- Oncology 125
- Geriatrics and Gerontology 17
- Molecular Biology 298
- Physiology 13
Countries citing papers authored by Junfei Cheng
This map shows the geographic impact of Junfei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfei Cheng more than expected).
Fields of papers citing papers by Junfei Cheng
This network shows the impact of papers produced by Junfei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfei Cheng. The network helps show where Junfei Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 82 | |
| 2 | 2019 | 66 | |
| 3 | 2020 | 57 | |
| 4 | 2022 | 54 | |
| 5 | 2022 | 30 | |
| 6 | 2022 | 23 | |
| 7 | 2024 | 19 | |
| 8 | 2022 | 15 | |
| 9 | 2018 | 7 | |
| 10 | 2024 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2024 | 1 |
About Junfei Cheng
Junfei Cheng is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 361 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (8 papers), Peptidase Inhibition and Analysis (3 papers), Quinazolinone synthesis and applications (2 papers), Biochemical and Molecular Research (2 papers), Mast cells and histamine (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Hematology (61 citations), Oncology (125 citations), Geriatrics and Gerontology (17 citations), Molecular Biology (298 citations) and Physiology (13 citations). Junfei Cheng has collaborated with scholars based in China. Frequent co-authors include Chunquan Sheng, Guoqiang Dong, Shipeng He, Ying Wu, Shanchao Wu, Yu Li, Xu Wang, Min Huang, Yahui Huang and Shuqiang Chen. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, ChemBioChem and Chinese Chemical Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.